The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Handling uncertainty when performing economic evaluation of healthcare interventions.
Open accessAbstract
NHS R&D HTA ProgrammeT he overall aim of the NHS R&D Health Technology Assessment (HTA) programme is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and work in the NHS.Research is undertaken in those areas where the evidence will lead to the greatest benefits to patients, either through improved patient outcomes or the most efficient use of NHS resources.The Standing Group on Health Technology advises on national priorities for health technology assessment.Six advisory panels assist the Standing Group in identifying and prioritising projects.These priorities are then considered by the HTA Commissioning Board supported by the National Coordinating Centre for HTA (NCCHTA).This report is one of a series covering acute care, diagnostics and imaging, methodology, pharmaceuticals, population screening, and primary and community care.It was identified as a priority by the Methodology Panel and funded as project number 93/48/07.The views expressed in this publication are those of the authors and not necessarily those of the Standing Group, the Commissioning Board, the Panel members or the Department of Health.The editors wish to emphasise that funding and publication of this research by the NHS should not be taken as implicit support for the recommendations for policy contained herein.In particular, policy options in the area of screening will be considered by the National Screening Committee.This Committee, chaired by the Chief Medical Officer, will take into account the views expressed here, further available evidence and other relevant considerations.Reviews in Health Technology Assessment are termed 'systematic' when the account of the search, appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,797
Statistical Methods in Medical Research.
Armitage, P. (1972) · Biometrics · doi:10.2307/2556182 · Cited by 4,029
An Introduction to the Bootstrap
Grimshaw, S. D., Efron, B., & Tibshirani, R. J. (1995) · Technometrics · doi:10.2307/1269918 · Cited by 2,095
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
Laupacis, A., Feeny, D. H., Detsky, A. S., & Tugwell, P. (1992) · Europe PMC (PubMed Central) · Cited by 1,581
The Threshold Approach to Clinical Decision Making
Pauker, S. G., & Kassirer, J. P. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005153022003 · Cited by 1,358
Explanatory and pragmatic attitudes in therapeutical trials
Schwartz, D., & Lellouch, J. (1967) · Journal of Chronic Diseases · doi:10.1016/0021-9681(67)90041-0 · Cited by 1,185
A study of the quality of life and cost-utility of renal transplantation
Laupacis, A., Keown, P., Pus, N., Krueger, H., Ferguson, B., Wong, C., & Muirhead, N. (1996) · Kidney International · doi:10.1038/ki.1996.307 · Cited by 1,167
Cited by
Bayesian Approaches to Clinical Trials and Health‐Care Evaluation
Spiegelhalter, D. J., Abrams, K. R., & Myles, J. P. (2003) · Wiley eBooks · doi:10.1002/0470092602 · Cited by 1,673
Representing uncertainty: the role of cost‐effectiveness acceptability curves
Fenwick, E., Claxton, K., & Sculpher, M. (2001) · Health Economics · doi:10.1002/hec.635 · Cited by 1,110
Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Fenwick, E., O'Brien, B. J., & Briggs, A. (2004) · Health Economics · doi:10.1002/hec.903 · Cited by 943
Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., Jonsson, B., Briggs, A., & Sullivan, S. D. (2015) · Value in Health · doi:10.1016/j.jval.2015.02.001 · Cited by 811
Self-citationHandling Uncertainty in Cost-Effectiveness Models
Briggs, A. H. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017050-00006 · Cited by 807
Ramsey, S., Willke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., Cook, J., Glick, H., Liljas, B., Petitti, D., et al. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.00045.x · Cited by 720
Generalized cost-effectiveness analysis for national-level priority-setting in the health sector
Hutubessy, R., Chisholm, D., Edejer, T. T.-T., & WHO-CHOICE (2003) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-1-8 · Cited by 535
Generalisability in economic evaluation studies in healthcare: a review and case studies
Sculpher, M., Pang, F., Manca, A., Drummond, M., Golder, S., Urdahl, H., Davies, L., & Eastwood, A. (2004) · Health Technology Assessment · doi:10.3310/hta8490 · Cited by 441
Hobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G. (2005) · Health Technology Assessment · doi:10.3310/hta9400 · Cited by 437
A guide to cost-effectiveness acceptability curves
Fenwick, E., & Byford, S. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.2.106 · Cited by 420
Briggs, A. H., Goeree, R., Blackhouse, G., & O'Brien, B. J. (2002) · Medical Decision Making · doi:10.1177/027298902400448867 · Cited by 414
Jarvik, J. G., Hollingworth, W., Martin, B., Emerson, S. S., Gray, D. T., Overman, S., Robinson, D., Staiger, T., Wessbecher, F., Sullivan, S. D., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2810 · Cited by 370
Moayyedi, P. (2000) · BMJ · doi:10.1136/bmj.321.7262.659 · Cited by 368
Bayesian methods in health technology assessment: a review.
Spiegelhalter, Myles, Jones, & Abrams (2000) · Health Technology Assessment · doi:10.3310/hta4380 · Cited by 358
Bower, P., Byford, S., Sibbald, B., Ward, E., King, M., Lloyd, M., & Gabbay, M. (2000) · BMJ · doi:10.1136/bmj.321.7273.1389 · Cited by 345
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
Döring, G., & Hoiby, N. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.03.008 · Cited by 304
Modelling in the economic evaluation of health care: selecting the appropriate approach
Barton, P., Bryan, S., & Robinson, S. (2004) · Journal of Health Services Research & Policy · doi:10.1258/135581904322987535 · Cited by 291
GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence
Brunetti, M., Shemilt, I., Pregno, S., Vale, L., Oxman, A. D., Lord, J., Sisk, J., Ruiz, F., Hill, S., Guyatt, G. H., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.04.012 · Cited by 286
Fenwick, E., Marshall, D. A., Levy, A. R., & Nichol, G. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-52 · Cited by 279
The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation
Briggs, A., & Gray, A. (1998) · Journal of Health Services Research & Policy · doi:10.1177/135581969800300410 · Cited by 272
Patel, V., Chisholm, D., Rabe-Hesketh, S., Dias-Saxena, F., Andrew, G., & Mann, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12119-8 · Cited by 217
Statistical Analysis of Cost‐effectiveness Data
Willan, A. R., & Briggs, A. H. (2006) · doi:10.1002/0470856289 · Cited by 155
Self-citationBrisson, M., & Edmunds, W. J. (2006) · Medical Decision Making · doi:10.1177/0272989x06290485 · Cited by 109
Clarke, P., Gray, A., Adler, A., Stevens, R., Raikou, M., Cull, C., Stratton, I., & Holman, R. (2001) · Diabetologia · doi:10.1007/s001250051617 · Cited by 99
CHISHOLM, D., DORAN, C., SHIBUYA, K., & REHM, J. (2006) · Drug and Alcohol Review · doi:10.1080/09595230600944487 · Cited by 86
Boyers, D., McNamee, P., Clarke, A., Jones, D., Martin, D., Schofield, P., & Smith, B. H. (2013) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e318250f539 · Cited by 46
Glazener, C., Breeman, S., Elders, A., Hemming, C., Cooper, K., Freeman, R., Smith, A., Hagen, S., Montgomery, I., Kilonzo, M., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20950 · Cited by 35
Kilonzo, M. M., Vale, L. D., Cook, J. A., Milne, A. C., Stephen, A. I., & Avenell, A. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2006.11.002 · Cited by 20
Metadata
- Authors
- Briggs, & Gray
- Venue
- Health Technology Assessment
- Published
- 1999
- Volume
- 3
- Issue
- 2
- Pages
- 1-134
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W1571272128
- Cited by
- 387
- References
- 256
- FWCI
- 51.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.